Tevogen Bio Stock (NASDAQ:TVGN)


Chart

Previous Close

$0.72

52W Range

$0.64 - $3.09

50D Avg

$0.84

200D Avg

$1.11

Market Cap

$138.01M

Avg Vol (3M)

$835.41K

Beta

-0.81

Div Yield

-

TVGN Company Profile


Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

18

IPO Date

Jan 05, 2022

Website

TVGN Performance


Peer Comparison


TickerCompany
SPROSpero Therapeutics, Inc.
ANROAlto Neuroscience, Inc.
ATOSAtossa Therapeutics, Inc.
MOLNMolecular Partners AG
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks